|
|
Effects of probiotics on insulin resistance and intestinal flora structure in patients with gestational diabetes mellitus#br# |
LIN Xuanxia1 HUANG Hanwei1 WU Ren1 WU Jing2 GU Xiulan3 ZHAN Yongying1 SU Qiong4 |
1.Department of Endocrinology, Zhongshan Chenxinghai Hospital, Guangdong Province, Zhongshan 528415, China;
2.Department of Nutriology, Zhongshan Chenxinghai Hospital, Guangdong Province, Zhongshan 528415, China;
3.Department of Obstetrics, Zhongshan Chenxinghai Hospital, Guangdong Province, Zhongshan 528415, China;
4.Department of Nephrology, Zhongshan Chenxinghai Hospital, Guangdong Province, Zhongshan 528415, China |
|
|
Abstract Objective To investigate the effects of probiotics on insulin resistance and intestinal flora structure in patients with gestational diabetes mellitus (GDM). Methods A total of 98 GDM patients admitted to Zhongshan Chenxinghai Hospital, Guangdong Province from January 2020 to January 2021 were selected and divided into two groups by random number table method, with 49 patients in each group. The control group was given insulin treatment, and the observation group was given probiotic treatment on the basis of the control group. After ten weeks of treatment, the therapeutic effects of the two groups were observed, and the differences of glycolipid metabolism, insulin resistance, intestinal flora structure, and pregnancy outcome were compared between the two groups. Results The total effective rate of observation group was higher than that control group, and the incidence of premature delivery and macrosomia was lower than that control group, the differences were statistically significant (P < 0.05). After treatment, total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), fasting blood glucose (FPG), 2 h postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1c), fasting insulin (FINS), and homeostasis model assessment- insulin resistance (HOMA-IR) index in two groups were all lower than those before freatment, high density lipoprotein cholesterol (HDL-C) was higher than that before treatment, the TC, TG, LDL-C, FPG, 2hPG, HbA1c, FINS, and HOMA-IR index in observation group were lower than those in control group, while HDL-C was higher than that in control group, the differences were statistically significant (P < 0.05). After treatment, the abundances of Rumen coccus, Bacteroides faecalis, Bacteroides monoform, Spirospira, Bacteroides multiform, and Bacteroides nodicum in the observation group were all higher than those before treatment, the abundances of Bifidobacterium, Eubacterium hallii, Eubacterium limosum, and Clostridium perfringens were all lower than those before treatment, while the abundances of Rumen coccus, Bacteroides faecalis, Bacteroides monoform, Spirospira, Bacteroides multiform, and Bacteroides nodicum in the observation group were all higher than those in control group, while the abundance of Bifidobacterium, Eubacterium hallii, Eubacterium limosum, and Clostridium perfringens were all lower than those in control group, the differences were statistically significant (P < 0.05). Conclusion The addition of probiotics on the basis of hypoglycemic treatment can correct the structural disorder of intestinal flora, inhibit insulin resistance, improve the disorder of glucose and lipid metabolism and pregnancy outcome of patients with GDM.
|
|
|
|
|
[1] 苏日娜,杨慧霞.美国糖尿病学会2019年“妊娠期糖尿病诊治指南”介绍(一)[J].中华围产医学杂志,2019,22(4):223-224.
[2] 蔡婷婷,鲁一兵,丁大法,等.肠道菌群与糖尿病和慢性肾病的相关性研究[J].海南医学院学报,2019,25(9):717-720.
[3] 陈莉,苏尧.肠道菌群与妊娠期糖尿病关系的研究进展[J].实用妇产科杂志,2021,37(3):199-202.
[4] 陈烨,朱明慧,王婵妮.益生菌补充对多囊卵巢综合征患者血糖和血脂的影响[J].国际妇产科学杂志,2018,45(2):199-202.
[5] 李丽,梁新政,祝开思,等.益生菌对超重糖尿病患者糖脂代谢及氧化应激水平的影响[J].中国临床保健杂志,2017,20(5):547-550.
[6] 中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病诊治指南(2014)[J].中华妇产科杂志,2014,49(8):561-569.
[7] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:157-160.
[8] 田也,麦旭东,马凯,等.肠道菌群调控代谢性疾病发生和发展[J].科学通报,2021,66(13):1602-1613.
[9] 刘莹,谭寅凤,张金月,等.超重肥胖和正常体重人群肠道菌群的差异分析[J].中国临床研究,2022,35(1):21-24.
[10] 郭鑫,吴飞飞.肠道菌群参与糖尿病肾病的发病机制研究进展[J].中国医学创新,2021,18(14):184-188.
[11] 王蕾蕾,陶晔璇.妊娠期糖尿病孕妇与健康孕妇的肠道菌群差异[J].上海交通大学学报:医学版,2019,39(11):1300-1305.
[12] Kuang YS,Lu JH,Li SH,et al. Connections between the human gut microbiome and gestational diabetes mellitus [J]. Gigascience,2017,6(8):1-12.
[13] 陈娟娟,袁凤刚.妊娠糖尿病患者脂联素、炎性因子水平与胰岛素抵抗的关系[J].河南医学研究,2019,28(5):809-810.
[14] 曹向可,钱庆增,赵金珩,等.妊娠期糖尿病患者肠道菌群改变及与炎症因子、免疫功能的相关性分析[J].中国糖尿病杂志,2018,26(6):451-454.
[15] 李荣琴,宋志英.肠道菌群失调与妊娠期糖尿病关系的研究进展[J].中国临床研究,2020,33(9):1285-1288, 1291.
[16] 刘侃,王秋明,宋婉玉,等.口服益生菌对妊娠期糖尿病小鼠肠道菌群及调节性免疫细胞的影响[J].中国微生态学杂志,2020,32(2):166-171.
[17] 张馨月.益生菌预防妊娠期糖尿病[J].中华围产医学杂志,2021,24(6):460.
[18] Hajifaraji M,Jahanjou F,Abbasalizadeh F,et al. Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers:a randomized clinical trial [J]. Asia Pac J Clin Nutr,2018,27(3):581-591.
[19] Houttu N,Mokkala K,Koivuniemi E,et al. The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation,IGFBP-1 and MMP-8 in Pregnancy:A Randomized,Placebo-Controlled,Double-Blind Clinical Trial [J]. Biomolecules,2020,11(1):5.
[20] Taylor BL,Woodfall GE,Sheedy KE,et al. Effect of Probiotics on Metabolic Outcomes in Pregnant Women with Gestational Diabetes:A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J]. Nutrients,2017,9(5):461.
[21] Han MM,Sun JF,Su XH,et al. Probiotics improve glucose and lipid metabolism in pregnant women:a meta-analysis [J]. Ann Transl Med,2019,7(5):99.
[22] 陈晔,王彦杰,尤利军,等.益生菌Probio-FitR联合二甲双胍对Ⅱ型糖尿病患者疗效及肠道菌群结构的影响[J].中国食品学报,2019,19(4):17-26.
[23] 周强,徐静.不同腹型肥胖程度青少年2型糖尿病患者肠道菌群变化及其与糖脂代谢和肝脏脂肪含量的关系[J].中国医药科学,2021,11(13):13-16.
[24] Reichardt N,Vollmer M,Holtrop G,et al. Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production [J]. ISME J,2018,12(2):610-622.
[25] 杨艳,叶佳,杨敏,等.益生菌结合维生素D对妊娠期糖尿病糖脂代谢、胰岛素抵抗的影响[J].解放军医药杂志,2020,32(11):71-74.
[26] 徐铭,郝思佳,王博夫,等.肠道菌群失调与2型糖尿病的相关性研究进展[J].中国实用乡村医生杂志,2021, 28(5):43-46.
[27] 吕思婷,刘赫,潘礼龙,等.妊娠期肠道菌群变化及益生菌干预研究进展[J].实用医学杂志,2018,34(23):3849-3853.
[28] 张心红,王凤英.妊娠期益生菌干预对母儿影响的研究进展[J].河北医药,2019,41(6):925-928. |
|
|
|